-
iMDx reports kidney transplant patient maintained graft without immunosuppression
-
Insight Molecular Diagnostics launches 5,000-patient registry study
-
Needham Reiterates Buy Rating on Insight Molecular Diagnostics Inc. (IMDX)
-
iMDx (IMDX) Reports Strong Head-to-Head Data in Kidney Transplant Rejection Testing

